Effect of Anemia on Hemorrhagic Complications and Mortality Following Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 99, Issue 11, 2007, Pages 1513-1517

  Voeltz, Michele D ^a   Patel, Amar D ^a   Feit, Frederick ^b   Fazel, Reza ^a   Lincoff, A Michael ^c   Manoukian, Steven V ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK;

AGED; ANEMIA; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CAUSE OF DEATH; DOUBLE-BLIND METHOD; FEMALE; HEPARIN; HIRUDINS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECOMBINANT PROTEINS; RESEARCH DESIGN; RISK FACTORS; TREATMENT OUTCOME;

EID: 34248673446     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.01.027     Document Type: Article

References (14)

1. Nikolsky E., Aymong E.D., Halkin A., Grines C.L., Cox D.A., Garcia E., Mehran R., Tcheng J.E., Griffin J.J., Guagliumi G., et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 44 (2004) 547-553
2. Moscucci M., Fox K.A., Cannon C.P., Klein W., Lopez-Sendon J., Montalescot G., White K., and Goldberg R.J. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 24 (2003) 1815-1823
3. Kinnaird T.D., Stabile E., Mintz G.S., Lee C.W., Canos D.A., Gevorkian N., Pinnow E.E., Kent K.M., Pichard A.D., Satler L.F., et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 92 (2003) 930-935
4. Gurm H.S., Lincoff A.M., Kleiman N.S., Kereiakes D.J., Tcheng J.E., Aronow H.D., Askari A.T., Brennan D.M., and Topol E.J. Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. Am J Cardiol 94 (2004) 30-34
5. Lee P.C., Kini A.S., Ahsan C., Fisher E., and Sharma S.K. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 44 (2004) 541-546
6. McKechnie R.S., Smith D., Montoye C., Kline-Rogers E., O'Donnell M.J., DeFranco A.C., Meengs W.L., McNamara R., McGinnity J.G., et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 110 (2004) 271-277
7. Nikolsky E., Mehran R., Aymong E.D., Mintz G.S., Lansky A.J., Lasic Z., Negoita M., Fahy M., Pocock S.J., Na Y., et al. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 94 (2004) 1023-1027
8. Lincoff A.M., Bittl J.A., Harrington R.A., Feit F., Kleiman N.S., Jackman J.D., Sarembock I.J., Cohen D.J., Spriggs D., Ebrahimi R., et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289 (2003) 853-863
9. Lincoff A.M., Kleiman N.S., Kereiakes D.J., Feit F., Bittl J.A., Jackman J.D., Sarembock I.J., Cohen D.J., Spriggs D., Ebrahimi R., et al. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA 292 (2004) 696-703
10. Rao A.K., Pratt C., Berke A., Jaffe A., Ockene I., Schreiber T.L., Bell W.R., Knatterud G., Robertson T.L., and Terrin M.L. Thrombolysis In Myocardial Infarction (TIMI) Trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 11 (1988) 1-11
11. World Health Organization. Nutritional Anemias: Report of a WHO Scientific Group (1968), World Health Organization, Geneva
12. Hebert P.C., Van der Linden P., Biro G., and Hu L.Q. Physiologic aspects of anemia. Crit Care Clin 20 (2004) 187-212
13. Levy P.S., Quigley R.L., and Gould S.A. Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery. J Trauma 41 (1996) 416-423
14. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023